🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine the effects of escalated dose of daunorubicin in induction treatm...
Status
Completed
Location
Asan Medical Center
Start Date
2001-08
Trial ID
NCT00474006
Treatments Being Tested
This project is a key clinical research project approved by the Clinical Re...
Status
Unknown
Location
First Affiliated Hospital of Xian Jiaotong University
Start Date
2021-09-06
Trial ID
NCT05026229
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
The purpose of this study is to determine the effectiveness of a particular...
Status
Completed
Location
The University of Chicago
Start Date
2002-12
Trial ID
NCT00774046
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Status
Recruiting
Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Start Date
2024-01-01
Trial ID
NCT06429098
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Start Date
2010-10
Trial ID
NCT01228331
RATIONALE: Drugs used in chemotherapy, such as cytarabine and clofarabine, ...
Status
Completed
Location
Wake Forest University Comprehensive Cancer Center
Start Date
2005-02
Trial ID
NCT00295841
Treatments Being Tested
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470